Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe
- 1 July 1998
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 105 (7) , 704-709
- https://doi.org/10.1111/j.1471-0528.1998.tb10199.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Timing of maternal-infant HIV transmissionAIDS, 1997
- Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to InfantNew England Journal of Medicine, 1996
- Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohortsAmerican Journal of Obstetrics and Gynecology, 1996
- Descriptive survey of antenatal HIV testing in London: policy, uptake, and detectionBMJ, 1996
- Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South AfricaThe Pediatric Infectious Disease Journal, 1996
- Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmissionThe Lancet, 1996
- Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical centerPublished by American Medical Association (AMA) ,1996
- The management of pregnancy and delivery in HIV-infected women in EuropeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1995
- Efficacy of Antenatal Zidovudine in Reducing Perinatal Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994